{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T07:18:47Z","timestamp":1771917527127,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Erciyes University Scientific Research Projects Coordination Unit","award":["THD-2024-13594"],"award-info":[{"award-number":["THD-2024-13594"]}]},{"name":"Erciyes University Scientific Research Projects Coordination Unit","award":["THD-2024-13594"],"award-info":[{"award-number":["THD-2024-13594"]}]},{"name":"Erciyes University Scientific Research Projects Coordination Unit","award":["THD-2024-13594"],"award-info":[{"award-number":["THD-2024-13594"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-025-02952-6","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T14:16:45Z","timestamp":1753366605000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["ROCK inhibition suppresses glioblastoma via a PTEN-associated reduction in PI3K\/AKT signaling"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7088-7490","authenticated-orcid":false,"given":"Ebru","family":"Uzunhisarc\u0131kl\u0131","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuh Mehmet","family":"Bozkurt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ay\u015fe","family":"Sa\u011flam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,24]]},"reference":[{"issue":"5 Suppl","key":"2952_CR1","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1188\/16.CJON.S1.2-8","volume":"20","author":"ME Davis","year":"2016","unstructured":"Davis ME. Glioblastoma: overview of disease and treatment. Clin J Oncol Nurs. 2016;20(5 Suppl):S2\u20138. https:\/\/doi.org\/10.1188\/16.CJON.S1.2-8.","journal-title":"Clin J Oncol Nurs"},{"key":"2952_CR2","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/B978-0-12-802997-8.00023-2","volume":"134","author":"HG Wirsching","year":"2016","unstructured":"Wirsching HG, Galanis E, Weller M. Glioblastoma. Handb Clin Neurol. 2016;134:381\u201397. https:\/\/doi.org\/10.1016\/B978-0-12-802997-8.00023-2.","journal-title":"Handb Clin Neurol"},{"issue":"4","key":"2952_CR3","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3322\/caac.21613","volume":"70","author":"AC Tan","year":"2020","unstructured":"Tan AC, Ashley DM, L\u00f3pez GY, Malinzak M, Friedman HS, Khasraw M. Management of glioblastoma: state of the art and future directions. CA Cancer J Clin. 2020;70(4):299\u2013312. https:\/\/doi.org\/10.3322\/caac.21613.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"2952_CR4","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1001\/archneurol.2010","volume":"67","author":"J Clarke","year":"2010","unstructured":"Clarke J, Butowski N, Chang S. Recent advances in therapy for glioblastoma. Arch Neurol. 2010;67(3):279\u201383. https:\/\/doi.org\/10.1001\/archneurol.2010.","journal-title":"Arch Neurol"},{"issue":"3","key":"2952_CR5","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3390\/biomedicines7030069","volume":"7","author":"H Strobel","year":"2019","unstructured":"Strobel H, Baisch T, Fitzel R, Schilberg K, Siegelin MD, Karpel-Massler G, Debatin K-M, Westhoff M-A. Temozolomide and other alkylating agents in glioblastoma therapy. Biomedicines. 2019;7(3):69. https:\/\/doi.org\/10.3390\/biomedicines7030069.","journal-title":"Biomedicines"},{"issue":"4","key":"2952_CR6","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1158\/1078-0432.CCR-12-3002","volume":"19","author":"H Ohgaki","year":"2013","unstructured":"Ohgaki H, Kleihues P. The definition of primary and secondary glioblastoma. Clin Cancer Res. 2013;19(4):764\u201372. https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-3002.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2952_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11060-011-0793-0","volume":"108","author":"FE Bleeker","year":"2012","unstructured":"Bleeker FE, Molenaar RJ, Leenstra S. Recent advances in the molecular understanding of glioblastoma. J Neurooncol. 2012;108(1):11\u201327. https:\/\/doi.org\/10.1007\/s11060-011-0793-0.","journal-title":"J Neurooncol"},{"issue":"5","key":"2952_CR8","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.2353\/ajpath.2007.070011","volume":"170","author":"H Ohgaki","year":"2007","unstructured":"Ohgaki H, Kleihues P. Genetic pathways to primary and secondary glioblastoma. Am J Pathol. 2007;170(5):1445\u201353. https:\/\/doi.org\/10.2353\/ajpath.2007.070011.","journal-title":"Am J Pathol"},{"issue":"6","key":"2952_CR9","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s00401-015-1432-1","volume":"129","author":"K Aldape","year":"2015","unstructured":"Aldape K, Zadeh G, Mansouri S, Reifenberger G, von Deimling A. Glioblastoma: pathology, molecular mechanisms and markers. Acta Neuropathol. 2015;129(6):829\u201348. https:\/\/doi.org\/10.1007\/s00401-015-1432-1.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"2952_CR10","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/s0028-3843(14)60408-4","volume":"44","author":"GA Alexiou","year":"2010","unstructured":"Alexiou GA, Voulgaris S. The role of the PTEN gene in malignant gliomas. Neurol Neurochir Pol. 2010;44(1):80\u20136. https:\/\/doi.org\/10.1016\/s0028-3843(14)60408-4.","journal-title":"Neurol Neurochir Pol"},{"issue":"3","key":"2952_CR11","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1215\/15228517-2007-003","volume":"9","author":"JK Wiencke","year":"2007","unstructured":"Wiencke JK, Zheng S, Jelluma N, Tihan T, Vandenberg S, Tamg\u00fcney T, Baumber R, Parsons R, Lamborn KR, Berger MS, Wrensch MR, Haas-Kogan DA, Stokoe D. Methylation of the PTEN promoter defines low-grade gliomas and secondary glioblastoma. Neuro Oncol. 2007;9(3):271\u20139. https:\/\/doi.org\/10.1215\/15228517-2007-003.","journal-title":"Neuro Oncol"},{"issue":"9","key":"2952_CR12","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.4161\/cbt.7.9.6954","volume":"7","author":"D Koul","year":"2008","unstructured":"Koul D. PTEN signaling pathways in glioblastoma. Cancer Biol Ther. 2008;7(9):1321\u20135. https:\/\/doi.org\/10.4161\/cbt.7.9.6954.","journal-title":"Cancer Biol Ther"},{"issue":"10","key":"2952_CR13","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.3390\/cancers14102412","volume":"14","author":"S Grochans","year":"2022","unstructured":"Grochans S, Cybulska AM, Simi\u0144ska D, Korbecki J, Kojder K, Chlubek D, Baranowska-Bosiacka I. Epidemiology of glioblastoma multiforme-literature review. Cancers. 2022;14(10):2412. https:\/\/doi.org\/10.3390\/cancers14102412.","journal-title":"Cancers"},{"key":"2952_CR14","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/s41419-018-0641-7","volume":"9","author":"R Zhang","year":"2018","unstructured":"Zhang R, Li G, Zhang Q, et al. Hirsutine induces mPTP-dependent apoptosis through ROCK1\/PTEN\/PI3K\/GSK3\u03b2 pathway in human lung cancer cells. Cell Death Dis. 2018;9:598. https:\/\/doi.org\/10.1038\/s41419-018-0641-7.","journal-title":"Cell Death Dis"},{"key":"2952_CR15","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1146\/annurev.pathol.4.110807.09231","volume":"4","author":"N Chalhoub","year":"2009","unstructured":"Chalhoub N, Baker SJ. PTEN and the PI3-kinase pathway in cancer. Annu Rev Pathol. 2009;4:127\u201350. https:\/\/doi.org\/10.1146\/annurev.pathol.4.110807.09231.","journal-title":"Annu Rev Pathol"},{"issue":"4","key":"2952_CR16","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3892\/ijo.2019.4864","volume":"55","author":"C Hu","year":"2019","unstructured":"Hu C, Zhou H, Liu Y, Huang J, Liu W, Zhang Q, Tang Q, Sheng F, Li G, Zhang R. ROCK1 promotes migration and invasion of non-small-cell lung cancer cells through the PTEN\/PI3K\/FAK pathway. Int J Oncol. 2019;55(4):833\u201344. https:\/\/doi.org\/10.3892\/ijo.2019.4864.","journal-title":"Int J Oncol"},{"issue":"2","key":"2952_CR17","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3892\/ijo.2020.5164","volume":"58","author":"MA Zakaria","year":"2021","unstructured":"Zakaria MA, Rajab NF, Chua EW, Selvarajah GT, Masre SF. Roles of Rho-associated kinase in lung cancer. Int J Oncol. 2021;58(2):185\u201398. https:\/\/doi.org\/10.3892\/ijo.2020.5164.","journal-title":"Int J Oncol"},{"issue":"4","key":"2952_CR18","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00005-015-0382-6","volume":"64","author":"L Wei","year":"2016","unstructured":"Wei L, Surma M, Shi S, Lambert-Cheatham N, Shi J. Novel insights into the roles of Rho kinase in cancer. Arch Immunol Ther Ex. 2016;64(4):259\u201378. https:\/\/doi.org\/10.1007\/s00005-015-0382-6.","journal-title":"Arch Immunol Ther Ex"},{"issue":"8","key":"2952_CR19","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1002\/jor.21403","volume":"29","author":"X Liu","year":"2011","unstructured":"Liu X, Choy E, Hornicek FJ, Yang S, Yang C, Harmon D, Mankin H, Duan Z. ROCK1 as a potential therapeutic target in osteosarcoma. J Orthop Res. 2011;29(8):1259\u201366. https:\/\/doi.org\/10.1002\/jor.21403.","journal-title":"J Orthop Res"},{"issue":"1","key":"2952_CR20","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1186\/s12885-017-3470-7","volume":"17","author":"CN Amaya","year":"2017","unstructured":"Amaya CN, Mitchell DC, Bryan BA. Rho kinase proteins display aberrant upregulation in vascular tumors and contribute to vascular tumor growth. BMC Cancer. 2017;17(1):485. https:\/\/doi.org\/10.1186\/s12885-017-3470-7.","journal-title":"BMC Cancer"},{"key":"2952_CR21","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s12885-022-09323-8","volume":"22","author":"Y Nie","year":"2022","unstructured":"Nie Y, Zhu X, Bu N, Jiang Y, Su Y, Pan K, Li S. Circ_0064288 acts as an oncogene of hepatocellular carcinoma cells by inhibiting miR-335-5p expression and promoting ROCK1 expression. BMC Cancer. 2022;22:265. https:\/\/doi.org\/10.1186\/s12885-022-09323-8.","journal-title":"BMC Cancer"},{"issue":"12","key":"2952_CR22","doi-asserted-by":"publisher","first-page":"108336","DOI":"10.1016\/j.cclet.2023.108336","volume":"34","author":"Y You","year":"2023","unstructured":"You Y, Zhu K, Wang J, Liang Q, Li W, Wang L, Guo B, Zhou J, Feng X, Shi J. ROCK inhibitor: focus on recent updates. Chin Chem Lett. 2023;34(12):108336. https:\/\/doi.org\/10.1016\/j.cclet.2023.108336.","journal-title":"Chin Chem Lett"},{"issue":"4","key":"2952_CR23","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.3892\/ijmm.2017.3103","volume":"40","author":"Q Wu","year":"2017","unstructured":"Wu Q, Ouyang C, Xie L, Ling Y, Huang T. The ROCK inhibitor, thiazovivin, inhibits human corneal endothelial-to-mesenchymal transition\/epithelial-to-mesenchymal transition and increases ionic transporter expression. Int J Mol Med. 2017;40(4):1009\u201318. https:\/\/doi.org\/10.3892\/ijmm.2017.3103.","journal-title":"Int J Mol Med"},{"issue":"2","key":"2952_CR24","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/scrt449","volume":"5","author":"S Chapman","year":"2014","unstructured":"Chapman S, McDermott DH, Shen K, Jang MK, McBride AA. The effect of Rho kinase inhibition on long-term keratinocyte proliferation is rapid and conditional. Stem Cell Res Ther. 2014;5(2):60. https:\/\/doi.org\/10.1186\/scrt449.","journal-title":"Stem Cell Res Ther"},{"issue":"8","key":"2952_CR25","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1038\/onc.2016.272","volume":"36","author":"JM Thompson","year":"2017","unstructured":"Thompson JM, Nguyen QH, Singh M, Pavesic MW, Nesterenko I, Nelson LJ, Liao AC, Razorenova OV. Rho-associated kinase 1 inhibition is synthetically lethal with von Hippel-Lindau deficiency in clear cell renal cell carcinoma. Oncogene. 2017;36(8):1080\u20139. https:\/\/doi.org\/10.1038\/onc.2016.272.","journal-title":"Oncogene"},{"issue":"6","key":"2952_CR26","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/S0891-5849(00)00508-6","volume":"30","author":"K Hor\u00e1kov\u00e1","year":"2001","unstructured":"Hor\u00e1kov\u00e1 K, \u0160ov\u010d\u0131\u0301kov\u00e1 A, Seemannov\u00e1 Z, Syrov\u00e1 D, Bu\u0161\u00e1nyov\u00e1 K, Drobn\u00e1 Z, Feren\u010d\u0131\u0301k M. Detection of drug-induced, superoxide-mediated cell damage and its prevention by antioxidants. Free Radic Biol Med. 2001;30(6):650\u201364. https:\/\/doi.org\/10.1016\/S0891-5849(00)00508-6.","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"2952_CR27","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.dental.2009.08.007","volume":"26","author":"E Urcan","year":"2010","unstructured":"Urcan E, Haertel U, Styllou M, Hickel R, Scherthan H, Reichl FX. Real-time xCELLigence impedance analysis of the cytotoxicity of dental composite components on human gingival fibroblasts. Dent Mater. 2010;26(1):51\u20138. https:\/\/doi.org\/10.1016\/j.dental.2009.08.007.","journal-title":"Dent Mater"},{"issue":"3","key":"2952_CR28","doi-asserted-by":"publisher","first-page":"217","DOI":"10.22037\/ijpr.2020.1101149","volume":"19","author":"XL Wu","year":"2020","unstructured":"Wu XL, Liu L, Wang QC, Wang HF, Zhao XR, Lin XB, Mei QB. Antitumor activity and mechanism study of riluzole and its derivatives. Iran J Pharm Res. 2020;19(3):217. https:\/\/doi.org\/10.22037\/ijpr.2020.1101149.","journal-title":"Iran J Pharm Res"},{"issue":"4","key":"2952_CR29","first-page":"187","volume":"20","author":"A Pazarba\u015f\u0131","year":"2011","unstructured":"Pazarba\u015f\u0131 A, Kasap M, Kasap H. Kanser yolaklari. Ar\u015fiv Kaynak Tarama Dergisi. 2011;20(4):187\u2013229.","journal-title":"Ar\u015fiv Kaynak Tarama Dergisi"},{"issue":"9","key":"2952_CR30","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/ncb839","volume":"4","author":"K Inoki","year":"2002","unstructured":"Inoki K, Li Y, Zhu T, Wu J, Guan KL. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat Cell Biol. 2002;4(9):648\u201357. https:\/\/doi.org\/10.1038\/ncb839.","journal-title":"Nat Cell Biol"},{"key":"2952_CR31","first-page":"2348","volume":"4","author":"DR Sushilkumar","year":"2016","unstructured":"Sushilkumar DR. Normal cell signaling pathways maintains \u2018stemness\u2019 in stem cells but aberrant pathways causes cells to transform into cancer cells\u2014a review. Int J Health Sci. 2016;4:2348\u2013572877.","journal-title":"Int J Health Sci"},{"key":"2952_CR32","doi-asserted-by":"publisher","first-page":"e998","DOI":"10.1038\/cddis.2013.519","volume":"5","author":"G Li","year":"2014","unstructured":"Li G, Liu L, Shan C, et al. RhoA\/ROCK\/PTEN signaling is involved in AT-101-mediated apoptosis in human leukemia cells in vitro and in vivo. Cell Death Dis. 2014;5:e998. https:\/\/doi.org\/10.1038\/cddis.2013.519.","journal-title":"Cell Death Dis"},{"issue":"5","key":"2952_CR33","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.3892\/mmr.2014.1982","volume":"9","author":"X Wan","year":"2014","unstructured":"Wan X, Cheng Q, Peng R, Ma Z, Chen Z, Cao Y, Jiang B. ROCK1, a novel target of miR-145, promotes glioma cell invasion. Mol Med Rep. 2014;9(5):1877\u201382. https:\/\/doi.org\/10.3892\/mmr.2014.1982.","journal-title":"Mol Med Rep"},{"issue":"1","key":"2952_CR34","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s13277-014-2673-7","volume":"36","author":"P Zhang","year":"2015","unstructured":"Zhang P, Lu Y, Liu XY, Zhou YH. Knockdown of Rho-associated protein kinase 1 suppresses proliferation and invasion of glioma cells. Tumour Biol. 2015;36(1):421\u20138. https:\/\/doi.org\/10.1007\/s13277-014-2673-7.","journal-title":"Tumour Biol"},{"key":"2952_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-018-0803-3","volume":"17","author":"N Haddadi","year":"2018","unstructured":"Haddadi N, Lin Y, Travis G, Simpson AM, Nassif NT, McGowan EM. PTEN\/PTENP1:\u2018regulating the regulator of RTK-dependent PI3K\/Akt signalling\u2019, new targets for cancer therapy. Mol Cancer. 2018;17:1\u201314. https:\/\/doi.org\/10.1186\/s12943-018-0803-3.","journal-title":"Mol Cancer"},{"issue":"6","key":"2952_CR36","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/WNF.0000000000000613","volume":"47","author":"J Lai","year":"2024","unstructured":"Lai J, Zhang X, Liang K. In vitro, experiment present ROCK2 inhibition promotes the therapeutic effect of Bevacizumab in the treatment of glioblastoma multiforme. Clin Neuropharmacol. 2024;47(6):193\u2013200. https:\/\/doi.org\/10.1097\/WNF.0000000000000613.","journal-title":"Clin Neuropharmacol"},{"issue":"2","key":"2952_CR37","doi-asserted-by":"publisher","first-page":"e483","DOI":"10.1038\/cddis.2013.10","volume":"4","author":"J Shi","year":"2013","unstructured":"Shi J, Wu X, Surma M, et al. Distinct roles for ROCK1 and ROCK2 in the regulation of cell detachment. Cell Death Dis. 2013;4(2):e483. https:\/\/doi.org\/10.1038\/cddis.2013.10.","journal-title":"Cell Death Dis"},{"key":"2952_CR38","doi-asserted-by":"publisher","first-page":"106474","DOI":"10.1016\/j.biocel.2023.106474","volume":"164","author":"YT Magalhaes","year":"2023","unstructured":"Magalhaes YT, Forti FL. ROCK inhibition reduces the sensitivity of mutant p53 glioblastoma to genotoxic stress through a Rac1-driven ROS production. Int J Biochem Cell Biol. 2023;164:106474. https:\/\/doi.org\/10.1016\/j.biocel.2023.106474.","journal-title":"Int J Biochem Cell Biol"},{"issue":"7","key":"2952_CR39","doi-asserted-by":"publisher","first-page":"e0132823","DOI":"10.1371\/journal.pone.0132823","volume":"10","author":"SG Tilson","year":"2015","unstructured":"Tilson SG, Haley EM, Triantafillu UL, Dozier DA, Langford CP, Gillespie GY, Kim Y. Rock inhibition facilitates in vitro expansion of glioblastoma stem-like cells. PLoS ONE. 2015;10(7):e0132823. https:\/\/doi.org\/10.1371\/journal.pone.0132823.","journal-title":"PLoS ONE"},{"issue":"2","key":"2952_CR40","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s11060-015-2044-2","volume":"127","author":"M He","year":"2016","unstructured":"He M, Luo M, Liu Q, et al. Combination treatment with fasudil and clioquinol produces synergistic anti-tumor effects in U87 glioblastoma cells by activating apoptosis and autophagy. J Neurooncol. 2016;127(2):261\u201370. https:\/\/doi.org\/10.1007\/s11060-015-2044-2.","journal-title":"J Neurooncol"},{"issue":"11","key":"2952_CR41","doi-asserted-by":"publisher","first-page":"875","DOI":"10.4161\/cbt.9.11.11634","volume":"9","author":"L Deng","year":"2010","unstructured":"Deng L, Li G, Li R, Liu Q, He Q, Zhang J. Rho-kinase inhibitor, fasudil, suppresses glioblastoma cell line progression in vitro and in vivo. Cancer Biol Ther. 2010;9(11):875\u201384. https:\/\/doi.org\/10.4161\/cbt.9.11.11634.","journal-title":"Cancer Biol Ther"},{"issue":"11","key":"2952_CR42","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1002\/stem.521","volume":"28","author":"J Sunayama","year":"2010","unstructured":"Sunayama J, Matsuda KI, Sat A, Tachibana K, Suzuk K, Narita Y, Kitanaka C. Crosstalk between the PI3K\/mTOR and MEK\/ERK pathways involved in the maintenance of self-renewal and tumorigenicity of glioblastoma stem-like cells. Stem Cells. 2010;28(11):1930\u20139.","journal-title":"Stem Cells"},{"issue":"2","key":"2952_CR43","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","volume":"149","author":"M Laplante","year":"2012","unstructured":"Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell. 2012;149(2):274\u201393.","journal-title":"Cell"},{"issue":"1","key":"2952_CR44","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/s41467-019-08481-x","volume":"10","author":"MK Park","year":"2019","unstructured":"Park MK, Yao Y, Xi W, Setijono SR, Kim JH, Vila IK, Song MS. PTEN self-regulates through USP11 via the PI3K-FOXO pathway to stabilize tumor suppression. Nat Commun. 2019;10(1):636.","journal-title":"Nat Commun"},{"issue":"4","key":"2952_CR45","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/35070009","volume":"3","author":"ML Coleman","year":"2001","unstructured":"Coleman ML, Sahai EA, Yeo M, Bosch M, Dewar A, Olson MF. Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I. Nat Cell Biol. 2001;3(4):339\u201345.","journal-title":"Nat Cell Biol"},{"issue":"11","key":"2952_CR46","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1038\/jcbfm.2012.126","volume":"32","author":"WM Pardridge","year":"2012","unstructured":"Pardridge WM. Drug transport across the blood\u2013brain barrier. J Cereb Blood Flow Metab. 2012;32(11):1959\u201372.","journal-title":"J Cereb Blood Flow Metab"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-02952-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-025-02952-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-02952-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T21:52:10Z","timestamp":1757281930000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-025-02952-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,24]]},"references-count":46,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["2952"],"URL":"https:\/\/doi.org\/10.1007\/s12032-025-02952-6","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,24]]},"assertion":[{"value":"30 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Since the article does not contain any studies with human or animal subjects, its approval by the ethics committee was not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors gave their consent for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"372"}}